2023-11-02 16:40:14 ET
- Evolent Health press release ( NYSE: EVH ): Q3 Non-GAAP EPS of $0.30 beats by $0.20 .
- Revenue of $511M (+44.9% Y/Y) beats by $1.15M .
- For the three months ending December 31, 2023, revenue is expected to be in the range of approximately $537 million to $557 million.
- Company is reiterating its previously-stated 2023 guidance for revenue, with revenue expected to be in the range of approximately $1.945 billion to $1.965 billion.
For further details see:
Evolent Health Non-GAAP EPS of $0.30 beats by $0.20, revenue of $511M beats by $1.15M